ATE114466T1 - Iontophoreseverfahren und -zusammensetzung. - Google Patents

Iontophoreseverfahren und -zusammensetzung.

Info

Publication number
ATE114466T1
ATE114466T1 AT91302220T AT91302220T ATE114466T1 AT E114466 T1 ATE114466 T1 AT E114466T1 AT 91302220 T AT91302220 T AT 91302220T AT 91302220 T AT91302220 T AT 91302220T AT E114466 T1 ATE114466 T1 AT E114466T1
Authority
AT
Austria
Prior art keywords
compositions
composition
delivery
vasodilator
iontophoresis
Prior art date
Application number
AT91302220T
Other languages
English (en)
Inventor
Burton H Sage Jr
James E Riviere
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/653,202 external-priority patent/US5302172A/en
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of ATE114466T1 publication Critical patent/ATE114466T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Paper (AREA)
  • Stringed Musical Instruments (AREA)
  • Control Of El Displays (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91302220T 1990-03-15 1991-03-15 Iontophoreseverfahren und -zusammensetzung. ATE114466T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49406290A 1990-03-15 1990-03-15
US07/653,202 US5302172A (en) 1990-03-15 1991-02-08 Method and composition for iontophoresis

Publications (1)

Publication Number Publication Date
ATE114466T1 true ATE114466T1 (de) 1994-12-15

Family

ID=27051282

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91302220T ATE114466T1 (de) 1990-03-15 1991-03-15 Iontophoreseverfahren und -zusammensetzung.

Country Status (11)

Country Link
EP (1) EP0449463B1 (de)
JP (1) JPH074432B2 (de)
AT (1) ATE114466T1 (de)
AU (1) AU634867B2 (de)
DE (1) DE69105322T2 (de)
DK (1) DK0449463T3 (de)
ES (1) ES2075934T3 (de)
FI (1) FI911268L (de)
IE (1) IE64873B1 (de)
NO (1) NO911021L (de)
NZ (1) NZ237333A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2863757B2 (ja) * 1992-02-17 1999-03-03 ドラッグ デリバリー システムズ インコーポレイテッド 電気的経皮薬剤アプリケータ
WO1994023748A1 (en) * 1993-04-08 1994-10-27 The University Of Queensland Administration of vaso-active agent and therapeutic agent
CA2252899A1 (en) * 1996-06-12 1997-12-18 Alza Corporation Enhanced electrotransport of therapeutic agents having polybasic anionic counter-ions
US6004577A (en) * 1997-08-12 1999-12-21 Murdock; Thomas O. Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions
US20060013769A1 (en) * 2004-07-16 2006-01-19 Stephen Carter Transdermal drug delivery formulations and method of determining optimal amounts of vasodilators therein
US20060013866A1 (en) * 2004-07-16 2006-01-19 Carter Stephen G Transdermal drug delivery formulations with optimal amounts of vasodilators therein
US20100028406A1 (en) * 2005-08-05 2010-02-04 Universite De Geneve Topical drug delivery by iontophoresis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659714A (en) * 1984-03-27 1987-04-21 Dentsply, Ltd. Anesthetic methods for mammals

Also Published As

Publication number Publication date
FI911268A0 (fi) 1991-03-14
DE69105322D1 (de) 1995-01-12
FI911268A7 (fi) 1991-09-16
JPH074432B2 (ja) 1995-01-25
EP0449463B1 (de) 1994-11-30
DK0449463T3 (da) 1995-01-23
IE64873B1 (en) 1995-09-20
AU634867B2 (en) 1993-03-04
JPH0679004A (ja) 1994-03-22
NO911021D0 (no) 1991-03-14
NO911021L (no) 1991-09-16
EP0449463A2 (de) 1991-10-02
FI911268L (fi) 1991-09-16
IE910715A1 (en) 1991-09-25
NZ237333A (en) 1993-08-26
ES2075934T3 (es) 1995-10-16
EP0449463A3 (en) 1991-12-27
AU7278591A (en) 1991-09-19
DE69105322T2 (de) 1995-05-18

Similar Documents

Publication Publication Date Title
SG49158A1 (en) Compositions and methods for topical administration of pharmaceutically active agents
CS318089A3 (en) Antiviral and antibacterial agent
ATE223745T1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
EP1478406A4 (de) Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
ES2123287T3 (es) Derivados 3-benzoil benzofuranicos como antagonistas de la hormona tiroidea.
BG103780A (en) Antitussive compositions
AU634867B2 (en) Method and composition for iontophoresis
MX9504023A (es) Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.
AU643760B2 (en) Method and composition for increased skin concentration of active agents by iontophoresis
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
ATE141506T1 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
NO882559L (no) Transdermalt leveringssystem for farmasoeytiske forbindelser.
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
IT1164389B (it) Derivati n-sostituiti dell'1-(4'-alchiltiofenil)-2-ammino-1,3-propandiolo
NZ237400A (en) Amino and quaternary ammonium derivatives of ascorbic acid; use in combating reperfusion damage
MX9702899A (es) Compuestos y composiciones para suministrar agentes activos.
IT1163571B (it) Derivati dell'isoindolina e composizioni terapeutiche che li comprendono come principio attivo
GR1001006B (el) Μεθοδος παρασκευης και χρησιμοποιησεως αντιιικων η αντιβακτηριακων συνθεσεων.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties